tiprankstipranks
Trending News
More News >
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market
Advertisement

Vivos Therapeutics (VVOS) Technical Analysis

Compare
211 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Vivos Therapeutics’s (VVOS) Moving Averages Convergence Divergence (MACD) indicator is 1.08, suggesting Vivos Therapeutics is a Sell.
Vivos Therapeutics’s (VVOS) 20-Day exponential moving average is 4.84, while Vivos Therapeutics’s (VVOS) share price is $6.74, making it a Buy.
Vivos Therapeutics’s (VVOS) 50-Day exponential moving average is 3.76, while Vivos Therapeutics’s (VVOS) share price is $6.74, making it a Buy.

Vivos Therapeutics (VVOS) Pivot Points

Jul 18, 2025, 02:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.10
6.35
6.54
6.79
6.98
7.23
7.42
Fibonacci
6.35
6.51
6.62
6.79
6.95
7.06
7.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vivos Therapeutics (VVOS) Moving Averages

Jul 18, 2025, 02:04 PM
Period
Simple
Exponential
MA5
6.65Sell
6.33Sell
MA10
5.78Buy
5.78Buy
MA20
4.39Buy
4.84Buy
MA50
3.23Buy
3.76Buy
MA100
3.09Buy
3.41Buy
MA200
3.38Buy
3.29Buy
Vivos Therapeutics’s (VVOS) 10-Day exponential moving average is 5.78, while Vivos Therapeutics’s (VVOS) share price is $6.74, making it a Buy.
Vivos Therapeutics’s (VVOS) 100-Day exponential moving average is 3.41, while Vivos Therapeutics’s (VVOS) share price is $6.74, making it a Buy.
Vivos Therapeutics’s (VVOS) stock price is $6.74 and Vivos Therapeutics’s (VVOS) 50-day simple moving average is 3.23, creating a Buy signal.
Vivos Therapeutics’s (VVOS) stock price is $6.74 and Vivos Therapeutics’s (VVOS) 100-day simple moving average is 3.09, creating a Buy signal.
Vivos Therapeutics’s (VVOS) stock price is $6.74 and Vivos Therapeutics’s (VVOS) 200-day simple moving average is 3.38, creating a Buy signal.

Vivos Therapeutics (VVOS) Technical Indicators

Jul 18, 2025, 02:04 PM
Name
Value
Implied Action
RSI (14)
71.46
Sell
STOCH (9,6)
67.64
Neutral
STOCHRSI (14)
72.71
Neutral
MACD (12,26)
1.08
Sell
ADX (14)
58.12
Sell
Williams %R
-38.84
Buy
CCI (14)
88.29
Neutral
ATR (14)
0.66
-
Ultimate Oscillator
55.21
Neutral
ROC
99.02
Buy
Vivos Therapeutics’s (VVOS) Relative Strength Index (RSI) is 71.46, creating a Sell signal.
Vivos Therapeutics’s (VVOS) Trend Strength Indicator (ADX) is 58.12, creating a Sell signal.
Vivos Therapeutics’s (VVOS) Commodity Channel Index (CCI) is 88.29, creating a Neutral signal.
Vivos Therapeutics’s (VVOS) Price Rate of Change (ROC) is 99.02, creating a Buy signal.

FAQ

Is VVOS a Buy, Hold, or Sell?
Based on VVOS’s technical indicators, VVOS is a Buy.
    What is VVOS’s RSI (14)?
    VVOS’s RSI (14) is 71.46, which suggests VVOS is a Sell.
      What is VVOS’s MACD?
      VVOS’s MACD is 1.08, which suggests VVOS is a Sell.
        What is VVOS’s 5-day moving average?
        VVOS’s 5-day moving average is 6.65, which suggests VVOS is a Sell.
          What is VVOS’s 20-day moving average?
          VVOS 20-day moving average is 4.39, which suggests VVOS is a Buy.
            What is VVOS’s 50-day moving average?
            VVOS’s 50-day moving average is 3.23, which suggests VVOS is a Buy.
              What is VVOS’s 200-day moving average?
              VVOS’s 200-day moving average is 3.38, which suggests VVOS is a Buy.
                What is VVOS’s Williams % R (14)?
                VVOS’s Williams % R (14) is -38.84, which suggests VVOS is a Buy.
                  What is VVOS’s CCI (14)?
                  VVOS’s CCI (14) is 88.29, which suggests VVOS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis